| Fairly positive investor analysis for $EGRX found at |
| @daniisable80 |
03/18/2020 3:47:38 AM |
| Eagle Pharmaceuticals to Discuss Fourth Quarter and Full |
| @billybilly3 |
02/21/2020 1:41:59 AM |
| Good Day Sprycel, |
| @NCIudice |
02/12/2020 2:39:02 AM |
| Good Day. Any hope here? With |
| @garfield |
02/11/2020 10:36:53 AM |
| Well after 2 years they got the FDA |
| @PurplePhantom |
02/22/2019 1:11:51 PM |
| They finally did it after 2 years: |
| @zKiPPccQ34z |
02/22/2019 1:10:58 PM |
| What is going on with this stock? Just |
| @wazzat1961 |
04/03/2018 3:06:02 PM |
| Scott Tariff on Biologics acquisition |
| @blortnoy |
02/26/2018 7:05:24 PM |
| http://investor.eagleus.com/press-release/eagle-pharmaceuticals-inc-reports-four |
| @dontknow |
02/26/2018 3:10:28 PM |
| WIth a market cap of 880 million and |
| @Mira |
02/13/2018 3:20:06 PM |
| Have not been here in quite a while, |
| @cleofoster |
02/12/2018 11:29:52 PM |
| Dew how much of the 700 EV for |
| @Lookleft |
12/11/2017 5:31:33 PM |
| big news Only 40 mil market cap cash |
| @montebelle |
11/17/2017 4:05:25 PM |
| Eagle Pharmaceuticals Announces Positive Results of Study Conducted |
| @lucmarin89 |
09/05/2017 6:52:28 PM |
| Suing the FDA for Bendeka's Orphan application was |
| @1dnenneman |
07/27/2017 3:26:53 PM |
| Classic Scott Tarriff.... A typical salesman without situational |
| @pinkman7 |
07/27/2017 2:56:24 PM |
| $EGRX receives CRL for Ryanodex in heatstroke: #msg-133316969. |
| @darylh |
07/26/2017 4:37:18 PM |
| Too hot to handle: Study shows Earth's killer |
| @Deimantele |
06/19/2017 5:45:46 PM |
| Class action lawsuit update |
| @Indra |
05/23/2017 4:39:50 PM |
| Replacing a CFO is one of the biggest |
| @vasvani |
05/17/2017 1:54:07 PM |
| What about at the beginning $CEO said more |
| @veerwatip |
05/11/2017 5:52:30 PM |
| Interesting comment from the Deutsche Bank conference about |
| @Sandy13426394 |
05/11/2017 4:50:06 PM |
| $EGRX is acting strange(strong), is buyout from$ TEVA |
| @New222 |
05/10/2017 5:38:34 PM |
| FDA Grants Priority Review for Eagle Pharmaceuticals Ryanodex |
| @mugs1957 |
03/27/2017 1:01:57 PM |
| $EGRX Financial Update as of 12/31/16 from JP |
| @thehill |
01/13/2017 12:38:01 AM |
| Eli Lilly's Alimta escapes early genericsand a sales |
| @autofxhu |
01/13/2017 12:07:18 AM |
| This was the first 2017 guidance for Bendeka/Treanda, |
| @chasgiv4 |
01/09/2017 2:47:24 PM |
| But why did $TEVA lower their sales guidance? |
| @Abeinvests |
01/09/2017 2:23:26 PM |
| Low 2017 sales guidance for Bendeks/Treanda. |
| @ethanjones |
01/09/2017 2:21:02 PM |
| What was the reasoning for the drop? |
| @eastjuntai |
01/09/2017 2:19:59 PM |
| $EGRX -7% on$ TEVAs 2017 guidance: #msg-127680719. |
| @Mstephen23 |
01/06/2017 6:56:00 PM |
| $MNTA's first$ NVS partnership deal (for generic Lovenox) |
| @ecraftindia |
12/19/2016 9:39:51 PM |
| Dew are you aware that $MNTA's former CEO |
| @cobberman |
12/19/2016 9:15:37 PM |
| Something to note here is that Eagle's largest |
| @zonlyz1 |
12/18/2016 4:50:45 PM |
| Instead of me trying to articulate why this |
| @C12Yianni |
11/17/2016 8:49:08 PM |
| msg was duplicated. Wouldn't let me delete this one. |
| @Darius540 |
11/17/2016 1:33:15 PM |
| "Who knows what Biogen and the other companies |
| @Ram |
11/17/2016 1:30:38 PM |
| Ryanodex is looking like its going to bring |
| @Ronandrae |
11/15/2016 3:08:41 PM |
| That's the problem with intellectual lightweights (Tarriff is |
| @rsimons48 |
11/13/2016 7:57:49 PM |
| I guess Biogen and 11 other companies that |
| @Gajravyas |
11/13/2016 2:40:38 AM |
| Agreed (eom). |
| @hhamish |
11/11/2016 4:15:27 PM |
| Dew, I fully understand your disappointment. |
| @abenson |
11/11/2016 4:13:40 PM |
| I cashed out today (#msg-126485051), so I'm resigning |
| @ya90278 |
11/11/2016 3:22:49 PM |
| I wasn't expecting this move (see bottom of |
| @thehydro |
11/11/2016 3:00:49 PM |
| Eagle Pharmaceuticals Initiates Rolling Submission of NDA for |
| @Green13 |
11/11/2016 2:41:55 PM |
| Eagle Pharmaceuticals Signs Definitive Agreement to Acquire Arsia |
| @btstttct10 |
11/11/2016 2:40:24 PM |
| Very nice! |
| @Marketwirenewstome |
11/09/2016 9:48:37 PM |
| In regards to milestone, the answer is yes |
| @mercury2107 |
11/09/2016 9:31:57 PM |
| Eagle Pharmaceuticals, Inc. Reports Third Quarter 2016 Results |
| @CoreyMofo |
11/09/2016 1:36:55 PM |
| The Bendeka "take-back" rights apply only when there |
| @GoatFry |
11/03/2016 5:49:51 PM |